Tudor Investment Corp’s BIO-REFERENCE LABS INC-NEW- BRLI Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2015
Q2
Sell
-21,100
Closed -$744K 1810
2015
Q1
$744K Sell
21,100
-7,510
-26% -$254K 0.02% 507
2014
Q4
$919K Buy
28,610
+6,910
+32% +$200K 0.03% 380
2014
Q3
$609K Buy
21,700
+1,983
+10% +$60.4K 0.02% 551
2014
Q2
$596K Buy
19,717
+4,317
+28% +$119K 0.02% 442
2014
Q1
$426K Sell
15,400
-15,798
-51% -$413K 0.02% 613
2013
Q4
$797K Buy
31,198
+12,298
+65% +$379K 0.04% 297
2013
Q3
$565K Buy
18,900
+900
+5% +$25K 0.02% 288
2013
Q2
$518K Buy
+18,000
New +$496K 0.04% 316

Other funds holding BRLI

Tudor Investment Corp's BRLI Position: Q2 2015 in Review

Tudor Investment Corp sold out of BIO-REFERENCE LABS INC-NEW- (BRLI) in Q2 2015, closing a stake of 21,100 shares — an estimated $744K sold.

Tudor Investment Corp first reported a position in BRLI in Q2 2013 and held it in 8 quarters. The position peaked at $919K in Q4 2014. 183 funds tracked by Wall St. Rank hold BRLI as of Q2 2015.

  • Tudor Investment Corp reported no remaining BIO-REFERENCE LABS INC-NEW- position as of Q2 2015 after selling out during the quarter.
  • Tudor Investment Corp sold 21,100 BIO-REFERENCE LABS INC-NEW- shares in Q2 2015, an estimated $744K.
  • Tudor Investment Corp first reported a position in BIO-REFERENCE LABS INC-NEW- in Q2 2013 and held it in 8 quarters.
  • Tudor Investment Corp's BIO-REFERENCE LABS INC-NEW- position peaked at $919K in Q4 2014.
  • 183 funds tracked by Wall St. Rank held BIO-REFERENCE LABS INC-NEW- as of Q2 2015.

Based on Tudor Investment Corp's 13F filing for Q2 2015, filed 14 Aug 2015.